× |
|
Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults PDF |
$40.00 |
|
$40.00 |
× |
|
Cannabinoid Hyperemesis Syndrome Presenting With Spontaneous Pneumomediastinum PDF |
$40.00 |
|
$40.00 |
× |
|
Breastfeeding and Antidepressants: Clinical Dilemmas and Expert Perspectives PDF |
$40.00 |
|
$40.00 |
× |
|
Novel Antipsychotics: Comparison of Weight Gain Liabilities PDF |
$40.00 |
|
$40.00 |
× |
|
Lockdown and Psychosis: A Paranoid Delusion PDF |
$40.00 |
|
$40.00 |
× |
|
Citalopram as Adjunctive Therapy in Bipolar Depression PDF |
$40.00 |
|
$40.00 |
× |
|
Management of Depression Induced by Interferon Hepatitis Therapies PDF |
$40.00 |
|
$40.00 |
× |
|
Pharmacogenomic Characterization of Childbearing-Aged Individuals With Mood Disorders in a Tertiary Care Perinatal Mental Health Clinic PDF |
$40.00 |
|
$40.00 |
× |
|
Perspectives on Perinatal Depression Treatment: Perinatal Psychiatry: The Challenges of Making Rational Treatment Decisions at the Interface of Psychiatry and Obstetrics PDF |
$40.00 |
|
$40.00 |
× |
|
The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long-Term Treatment PDF |
$40.00 |
|
$40.00 |
× |
|
Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis PDF |
$40.00 |
|
$40.00 |
× |
|
Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000 PDF |
$40.00 |
|
$40.00 |
× |
|
The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs. PDF |
$40.00 |
|
$40.00 |
|